IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2020 to Q1 2025

Type / Class
Equity / Class A common stock, $0.001 par value
Symbol
CYTH
Shares outstanding
162,474,849
Price per share
$0.70
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 9.9% $11,305,000 16,150,000 Armistice Capital, LLC 30 Jun 2025

Institutional Holders of IRONWOOD PHARMACEUTICALS INC - Class A common stock, $0.001 par value (CYTH) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q1 0 $0 -$927,701 $0.70 0
2024 Q4 2,261,772 $1,334,489 -$9,941 $0.59 20
2024 Q3 2,277,442 $1,796,934 -$4,523 $0.79 18
2024 Q2 2,236,707 $2,840,724 +$93,027 $1.27 22
2024 Q1 2,163,455 $3,006,983 +$1,189,900 $1.39 22
2023 Q4 1,297,239 $2,062,486 +$1,299,953 $1.59 20
2023 Q3 480,977 $682,748 +$31,999 $1.42 17
2023 Q2 456,356 $725,118 -$370,673 $1.59 14
2023 Q1 973,845 $818,172 -$267,967 $0.84 13
2022 Q4 1,286,580 $1,827,039 +$1,237,084 $1.42 13
2022 Q3 396,578 $766,000 -$7,491 $1.94 9
2022 Q2 400,271 $790,000 -$24,661 $1.98 8
2022 Q1 433,448 $1,373,000 -$89,693 $3.17 10
2021 Q4 444,227 $1,656,000 +$471,090 $3.73 11
2021 Q3 330,881 $2,233,000 +$455,099 $6.75 12
2021 Q2 263,669 $2,696,000 +$1,997,209 $10.22 10
2021 Q1 71,378 $585,000 -$3,339,348 $8.19 8
2020 Q4 593,267 $2,581,000 +$1,057,998 $4.35 7